New hope for hyperlipidemia management: Inclisiran
- 1 May 2018
- journal article
- letter
- Published by Elsevier in Journal of Cardiology
- Vol. 71 (5) , 523-524
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Phosphorothioate backbone modifications of nucleotide-based drugs are potent platelet activatorsJournal of Experimental Medicine, 2015
- Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primatesProceedings of the National Academy of Sciences, 2008
- Proprotein convertase subtilisin/kexin type 9 (PCSK9)Hepatology, 2008